WHO proposal to exempt biosimilar trials to trigger biotech generics boom
The proposal, once approved and adopted by member countries, could trigger a bigger interest in developing generic versions of biotech medicines in India.
The proposal, once approved and adopted by member countries, could trigger a bigger interest in developing generic versions of biotech medicines in India.